default author photo

Ariel Raskin

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

41

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing Sars-Cov-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial

Number of pages: 26 Posted: 30 May 2024
Thiem Dinh Vu, Duc-Anh Dang, Vu Hai Ha, Nguyen Van Thom, Thang Cong Tran, Jose Mateus, Juan Manuel Carreño, Rama Raghunandan, Huong Mai Nguyen, Laina D. Mercer, Jorge Flores, E. Alexandar Escarrega, Ariel Raskin, Thai Huu Duong, Be Van Le, Alessandro Sette, Bruce L. Innis, Florian Krammer and Daniela Weiskopf
National Institute of Hygiene and Epidemiology, National Institute of Hygiene and Epidemiology, National Institute of Hygiene and Epidemiology, affiliation not provided to SSRN, PATH, La Jolla Institute for Allergy and Immunology (LIAI), affiliation not provided to SSRN, PATH, PATH, PATH, PATH, La Jolla Institute for Allergy and Immunology (LIAI), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, PATH, Icahn School of Medicine at Mount Sinai - Department of Microbiology and La Jolla Institute for Allergy and Immunology (LIAI)
Downloads 41 (1,170,409)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine, Phase II clinical trial